Genentech Drug Helps Post-Surgery Breast Cancer (Reuters)


Reuters - Genentech Inc. said on Monday its
breast cancer drug Herceptin improved survival in certain women
with early-stage cancer who underwent surgery, sending its
shares up 10 percent in after-hours trading

Read more...